David E. Moller
Impact in
-
- Diabetes Treatment and Management
- Physiology top 0.1%
- Adipose Tissue and Metabolism
Papers in
-
- Metabolism, Diabetes, and Cancer 65
- Peroxisome Proliferator-Activated Receptors 62
- Protein Kinase Regulation and GTPase Signaling 13
- Receptor Mechanisms and Signaling 12
- Physiology 56
- Adipose Tissue and Metabolism 53
- Co-authors
- Joel P. Berger (37 shared papers)Gaochao Zhou (19 shared papers)Thomas W. Doebber (24 shared papers)Jeffrey S. Flier (26 shared papers)Laurie J. Goodyear (7 shared papers)Margaret Wu (14 shared papers)John Ventre (8 shared papers)Yuli Chen (4 shared papers)
- Journals
- Journal of Biological Chemistry (22 papers)Diabetes (19 papers)Endocrinology (13 papers)Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Medicinal Chemistry (7 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
David E. Moller
168 papers receiving 25.6k citations
David E. Moller's Hit Papers
Peers
Comparison fields: 5 of 154
- Endocrinology, Diabetes and Metabolism 5.0k
- Physiology 6.2k
- Molecular Biology 16.1k
- Biochemistry 1.5k
- Endocrine and Autonomic Systems 952
Countries citing papers authored by David E. Moller
This map shows the geographic impact of David E. Moller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Moller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Moller more than expected).
Fields of papers citing papers by David E. Moller
This network shows the impact of papers produced by David E. Moller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Moller. The network helps show where David E. Moller may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Moller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of AMP-activated protein kinase in mechanism of metformin action Hit paper breakdown → | 2001 | 4632 |
| 2 | The Mechanisms of Action of PPARs Hit paper breakdown → | 2002 | 2232 |
| 3 | Fibroblast Growth Factor 21 Corrects Obesity in Mice Hit paper breakdown → | 2008 | 905 |
| 4 | New drug targets for type 2 diabetes and the metabolic syndrome Hit paper breakdown → | 2001 | 895 |
| 5 | The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes Hit paper breakdown → | 2013 | 748 |
| 6 | Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes Hit paper breakdown → | 2002 | 691 |
| 7 | Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Hit paper breakdown → | 2000 | 603 |
| 8 | Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. Hit paper breakdown → | 1996 | 570 |
| 9 | Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta Hit paper breakdown → | 1999 | 530 |
| 10 | Metabolic Syndrome: A Clinical and Molecular Perspective Hit paper breakdown → | 2004 | 521 |
| 11 | Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization Hit paper breakdown → | 2002 | 511 |
| 12 | 2001 | 409 | |
| 13 | 2006 | 392 | |
| 14 | 1999 | 384 | |
| 15 | 1996 | 349 | |
| 16 | 2003 | 302 | |
| 17 | 1990 | 286 | |
| 18 | 1996 | 283 | |
| 19 | 2003 | 283 | |
| 20 | 1993 | 281 |
About David E. Moller
David E. Moller is a scholar working on Molecular Biology, Physiology, Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 173 papers that have together received 26.5k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (65 papers), Peroxisome Proliferator-Activated Receptors (62 papers), Adipose Tissue and Metabolism (53 papers), Pancreatic function and diabetes (31 papers), Adipokines, Inflammation, and Metabolic Diseases (20 papers), Diabetes Treatment and Management (14 papers), Protein Kinase Regulation and GTPase Signaling (13 papers) and Receptor Mechanisms and Signaling (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.0k citations), Physiology (6.2k citations), Molecular Biology (16.1k citations), Biochemistry (1.5k citations) and Endocrine and Autonomic Systems (952 citations). David E. Moller has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Joel P. Berger, Gaochao Zhou, Thomas W. Doebber, Jeffrey S. Flier, Laurie J. Goodyear, Margaret Wu, John Ventre, Yuli Chen, Michael F. Hirshman and Nicolas Musi. Their work appears in journals such as Journal of Biological Chemistry, Diabetes, Endocrinology, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.